Acute coronary syndrome

12 trials 7 recruiting MedDRA PT
12 Registered trials
7 Recruiting
10 Unique sponsors
9 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 4
B Haematology (ATC B) 7
C Cardiology (ATC C) 2
A Gastroenterology (ATC A) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 5 substances
Antiplatelet / NSAID 1 substance
Statin 1 substance
ACE inhibitor 1 substance
GLP-1 receptor agonist 1 substance
Phase III: 6 Phase III/IV: 2 Phase IV: 4

Filter these 12 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 12 trials

Phase III

6 trials
  • Novartis Pharma AG Commercial
    IMP not specified
    2025-521670-34-00 5 countries 2026 n=135
    Recruiting
  • Azienda Ospedaliera Universitaria Gaetano Martino Messina Academic
    CLOPIDOGREL; PRASUGREL
    2023-509868-20-00 1 country 2023 n=200
    Recruiting
  • Insel Gruppe AG Academic
    IMP not specified
    2023-509717-36-00 7 countries 2024 n=1,700
    Recruiting
  • Medical University Of Gdansk Academic
    TICAGRELOR
    2024-515056-20-00 1 country 2021 n=2,230
    Ended
  • Nicolaus Copernicus University Academic
    ACETYLSALICYLIC ACID; TICAGRELOR
    2024-518090-34-00 1 country 2022 n=4,500
    Ended
  • Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy Academic
    IMP not specified
    2024-516589-13-00 1 country n=1,000
    Pending

Phase III/IV

2 trials
  • Fundacion Epic Academic
    CLOPIDOGREL; PRASUGREL; TICAGRELOR
    2024-512436-29-00 1 country 2026 n=634
    Recruiting
  • Fundacion Epic Academic
    ACETYLSALICYLIC ACID; ATORVASTATIN; RAMIPRIL; RAMIPRIL, ACETYLSALICYLIC ACID, ATORVASTATIN CALCIUM TRIHYDRATE
    2024-518705-18-00 1 country 2026 n=88
    Recruiting

Phase IV

4 trials
  • Azienda Ospedaliero-Universitaria Maggiore Della Carita Academic
    SEMAGLUTIDE
    2025-523977-40-00 1 country n=90
    Pending
  • Fondazione Ricerca e Innovazione Cardiovascolare Academic
    IMP not specified
    2024-519706-13-00 4 countries 2026 n=576
    Recruiting
  • Fundacion Epic Academic
    ACETYLSALICYLIC ACID; ATORVASTATIN; RAMIPRIL; RAMIPRIL, ACETYLSALICYLIC ACID, ATORVASTATIN CALCIUM TRIHYDRATE
    2025-524751-32-00 1 country n=216
    Pending
  • Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA Academic
    FERRIC CARBOXYMALTOSE
    2025-522421-36-00 1 country 2026 n=538
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Fundacion Epic Academic 3 Phase III/IV, Phase IV 2
Novartis Pharma AG Commercial 1 Phase III 1
Azienda Ospedaliera Universitaria Gaetano Martino Messina Academic 1 Phase III 1
Insel Gruppe AG Academic 1 Phase III 1
Medical University Of Gdansk Academic 1 Phase III 0
Nicolaus Copernicus University Academic 1 Phase III 0
Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy Academic 1 Phase III 0
Azienda Ospedaliero-Universitaria Maggiore Della Carita Academic 1 Phase IV 0
Fondazione Ricerca e Innovazione Cardiovascolare Academic 1 Phase IV 1
Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA Academic 1 Phase IV 1
New trials by year
2021
1
2022
1
2023
1
2024
1
2026
5
← All indication landscapes